CB
NVO

CNB Bank’s Novo Nordisk NVO Stock Holding History

CNB Bank’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-250
Closed -$13.9K – 518
2025
Q3 		$13.9K Sell
250
-30
-11% -$1.76K 0.01% 383
2025
Q2 		$19.3K Hold
280
– – 0.01% 331
2025
Q1 		$19.4K Hold
280
– – 0.01% 314
2024
Q4 		$24.1K Hold
280
– – 0.01% 302
2024
Q3 		$33.3K Buy
280
+30
+12% +$4K 0.02% 294
2024
Q2 		$35.7K Hold
250
– – 0.02% 279
2024
Q1 		$32.1K Hold
250
– – 0.02% 287
2023
Q4 		$25.9K Buy
+250
New +$24.7K 0.01% 298

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

CNB Bank's NVO Position: Q4 2025 in Review

CNB Bank sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 250 shares — an estimated $13.9K sold.

CNB Bank first reported a position in NVO in Q4 2023 and held it in 8 quarters. The position peaked at $35.7K in Q2 2024. 1,418 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

  • CNB Bank reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
  • CNB Bank sold 250 Novo Nordisk shares in Q4 2025, an estimated $13.9K.
  • CNB Bank first reported a position in Novo Nordisk in Q4 2023 and held it in 8 quarters.
  • CNB Bank's Novo Nordisk position peaked at $35.7K in Q2 2024.
  • 1,418 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on CNB Bank's 13F filing for Q4 2025, filed 11 Feb 2026.